Let’s Talk About Benefits – A Conversation Between Top Benefits Leaders on What to Expect in 2023

In a recent discussion between Sanjay Motwani Artemis’ GM, Matt Grapentine of Mercer, Leah Motl of Holmes Murphy, and Kerry Gross Arizent’s Director of Research Intelligence, benefits leaders reacted to the results of our annual study that identified the top goals and pain points in the benefits space.

How Ozempic Off-label Use Could Impact Employers’ Checkbooks and American’s Waistlines

From SNL skits to an abundance of news headlines, everyone seems to be talking about Ozempic, but how prevalent is this buzzword drug in your population? Here’s everything employers and HR leaders need to know about diabetic medication turned cultural weight loss sensation...

Artemis Partners with SimpleTherapy to Help Health Plans, Employers Evaluate and Provide Musculoskeletal Care

Artemis announces a partnership with SimpleTherapy’ that will provide employers and health plans the ability to independently evaluate and manage members’ MSK needs. SimpleTherapy’s virtual-first approach and in-person care options ensure increased access, improved outcomes and cost control for employers and plans. Clients report an 18% reduction in MSK treatment costs and members report an average of 65% pain reduction, with 89% experiencing improvement in two to three weeks.

6 Ways to Improve Women’s Health Equity

Gender equity is a cause many companies are still fighting to achieve. One area in particular to improve women’s equity is in company health and wellness programs.

Daylight Savings: When Clocks Go Forward, Your Members' Health Goes Back

Daylight savings provokes an onslaught of articles twice a year. We wanted to see if our book of business reflected or rejected some of the headlines and health claims you’ll see this weekend as clocks in 48 out of 50 states spring forward.

Why Heart Health Matters to Employers

On average, $216 billion is spent within the healthcare system to treat cardiovascular disease. Yet, that is not the only price incurred by the condition. CVD also costs employers $147 billion in lost productivity.